AbbVie Inc. (ABBV) Presents at 4th Annual Wolfe Research Heajust a thought..
Q1 for skin quality could be SBM inside (?)
As we think about just the portfolio overall, if the things that will bring new patients and returning patients into those practices, things like we're launching Botox, the filler line or jawline, skin bev [ph] and Q1 for skin quality. So we're still investing in this business. We're looking for driving innovation, finding ways of driving those consumers into the practices, although the growth has slowed but it does rebound very quickly as we've mentioned before.
also, the last question around obesity sounds like a potential future opportunity for Sirona, in case things work out with TFC-1067 and maybe TFC-1326 as a third AbbVie collaboration
AbbVie Inc. (ABBV) Presents at 4th Annual Wolfe Research Healthcare Conference | Seeking Alpha